NCT03731364View on ClinicalTrials.gov

Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

May 31, 2019

Conditions
Postsurgical Pain
Interventions
DRUG

CA-008

5 mg CA-008 (0.05 mg/mL), 10 mg CA-008 (0.1 mg/mL) and 15 mg CA-008 (0.15 mg/mL)

DRUG

Placebo

Placebo

Trial Locations (1)

77402

HD Research, Houston

Sponsors
All Listed Sponsors
lead

Concentric Analgesics

INDUSTRY

NCT03731364 - Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter